Publications by authors named "Philippe-Alexandre Gilbert"

Claim this Profile
W
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin.
Maria Dul, Mohammed Alali, Mahmoud Ameri, Matthew Douglas Burke, Benjamin Paul Creelman, Philippe-Alexandre Gilbert

J Control Release· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release.
Franz Schnetzinger, Didier Clénet, Philippe-Alexandre Gilbert, Antonio Guzzi, Marilena Paludi

Vaccines (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
Maria Dul, Mohammed Alali, Mahmoud Ameri, Matthew Douglas Burke, Christine M Craig, Philippe-Alexandre Gilbert

J Control Release· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Tiziana Scarnà, Marion Menozzi-Arnaud, Martin Friede, Kerry DeMarco, George Plopper, Philippe Alexandre Gilbert

Expert Opin Drug Deliv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report.
Laura Viviani, Kirsty Reid, Thierry Gastineau, Catherine Milne, Dean Smith, Philippe Alexandre Gilbert

Biologicals· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Mateusz Hasso-Agopsowicz, Natasha Crowcroft, Robin Biellik, Christopher J Gregory, Marion Menozzi-Arnaud, Philippe-Alexandre Gilbert

Front Public Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity.
Jin Su, Christy Willert, Lacrimioara Comanita, Andrew Peters, Philippe-Alexandre Gilbert

Virology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.
Marianne M Stanford, Mae Shaban, John W Barrett, Steven J Werden, Philippe-Alexandre Gilbert

Mol Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
John W Barrett, Lindsay R Alston, Fuan Wang, Marianne M Stanford, Philippe-Alexandre Gilbert

J Neurovirol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.
Marianne M Stanford, John W Barrett, Philippe-Alexandre Gilbert, Richard Bankert, Grant McFadden

J Virol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus.
Philippe-Alexandre Gilbert, Amine Kamen, Alice Bernier, Alain Garnier

Biotechnol Bioeng· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poxvirus cancer therapy.
Philippe-Alexandre Gilbert, Grant McFadden

Recent Pat Antiinfect Drug Discov· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status for High Titre Poxvirus Stock Preparation in CEF Under Serum-Free Medium Conditions: Implication for Vaccine Development.
Philippe-Alexandre Gilbert, Lacrimioara Comanita, John Barrett, Andrew Peters, Marta Szabat

Cytotechnology· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis